| Followers | 79 |
| Posts | 12252 |
| Boards Moderated | 3 |
| Alias Born | 06/03/2008 |
Wednesday, February 11, 2026 11:23:56 AM
Now today, finally 1% of the "Free dividend" shares have traded in the last 2 days, and the result so far is the price has fallen from 0.027 to 0.0032, meaning in 1.5 trading days the price has fallen by 88%!
There are millions and millions more shares to be sold folks! Only 1.8 million of the 139 million new shares have hit the market so far! This is a fascinating easily predictable disaster! And if you couldn't see this happening, then your losses are you fault, not the market's and not the CEO's!
There are millions and millions more shares to be sold folks! Only 1.8 million of the 139 million new shares have hit the market so far! This is a fascinating easily predictable disaster! And if you couldn't see this happening, then your losses are you fault, not the market's and not the CEO's!
Recent RGBPP News
- Form 8-K - Current report • Edgar (US Regulatory) • 03/04/2026 07:49:53 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/13/2026 11:13:01 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/02/2026 08:49:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/21/2026 11:01:54 AM
- Form QUALIF - Notice of Qualification [Regulation A] • Edgar (US Regulatory) • 01/13/2026 05:15:05 AM
- Form 1-A POS - • Edgar (US Regulatory) • 01/08/2026 06:00:40 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 12/30/2025 03:38:37 PM
- Form 253G1 - • Edgar (US Regulatory) • 12/05/2025 08:57:53 PM
- Form 1-A - Offering Statement [Regulation A] • Edgar (US Regulatory) • 11/17/2025 12:21:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2025 04:57:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/03/2025 10:06:02 AM
- Regen BioPharma Update on Orphan Drug Application for HemaXellerate Will Be Presented At Emerging Growth Conference on September 24, 2025 • GlobeNewswire Inc. • 09/23/2025 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/19/2025 05:12:32 PM
- Regen BioPharma Prepares Response For FDA Regarding Its Orphan Drug Application for HemaXellerate • GlobeNewswire Inc. • 09/16/2025 12:00:00 PM
- Form 1-A - Offering Statement [Regulation A] • Edgar (US Regulatory) • 08/29/2025 08:00:45 PM
- Form 1-A-W - Withdrawal of offering statement [Regulation A] • Edgar (US Regulatory) • 08/12/2025 08:52:19 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/11/2025 10:18:01 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/07/2025 07:19:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/01/2025 07:23:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/11/2025 03:15:34 PM
